Skip to main content

Table 7 Comorbidity and ADR

From: Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Comorbidity Number of patients Patients with ADR P value#
Cancer 4 3 (75.0%) 0.006
Obesity 7 5 (71.4%) 0.001
Chronic kidney disease 38 19 (50.0%) < 0.001
Cardiovascular diseases 58 23 (39.7%) < 0.001
Hypertension 249 75 (30.1%) < 0.001
Diabetes mellitus 157 46 (29.3%) 0.002
Chronic obstructive lung disease 4 1 (25.0%) 0.814
Asthma 47 10 (21.3%) 0.862
  1. Patients with ADR are reported as n (%), where % is calculated by patients with ADR/number of patients
  2. #Analysed with Chi-square (X2) test